Should You Sell Creative Medical Technology Holdings Inc (CELZ) in Biotechnology Industry?

Creative Medical Technology Holdings Inc (CELZ) is around the top of the Biotechnology industry according to InvestorsObserver. CELZ received an overall rating of 51, which means that it scores higher than 51 percent of all stocks. Creative Medical Technology Holdings Inc also achieved a score of 70 in the Biotechnology industry, putting it above 70 percent of Biotechnology stocks. Biotechnology is ranked 64 out of the 148 industries.

CELZ has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on CELZ!

See Full CELZ Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Creative Medical Technology Holdings Inc Stock Today?

Creative Medical Technology Holdings Inc (CELZ) stock is trading at $2.89 as of 10:37 AM on Thursday, Apr 14, a decline of -$0.04, or -1.37% from the previous closing price of $2.93. The stock has traded between $2.87 and $3.04 so far today. Volume today is light. So far 127,543 shares have traded compared to average volume of 7,873,430 shares. Click Here to get the full Stock Report for Creative Medical Technology Holdings Inc stock.